No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
Courthouse News Service1d
Judge blocks Trump’s $4 billion cuts to biomedical research after lawsuit from 22 states
(CN) — A federal judge has temporarily blocked an expected $4 billion slash to funding for biomedical research after a group ...
Mass.-based Moderna could be first to manufacture bird flu vaccine
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Hosted on MSN28d
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed the mark in a cytomegalovirus study. Please watch the video at Investors.com - How To Buy ...
Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Yahoo Finance25d
Moderna Gets $590 Million from US to Study Bird Flu Vaccine
Based on positive preliminary data, Moderna is preparing to advance the vaccine into a late-stage study. Meanwhile, US public health officials are stepping up efforts to detect and contain the ...
Yahoo Finance25d
Moderna Announces Updates on Pandemic Influenza Program
In 2023, Moderna initiated a Phase 1/2 study to generate safety and immunogenicity data of an investigational pandemic influenza vaccine (mRNA-1018) in healthy adults aged 18 years and older.
CNN25d
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...
Business Insider25d
Moderna confirms $590M award by U.S. for bird flu vaccine development
In 2023, Moderna initiated a Phase 1/2 study to generate safety and immunogenicity data of an investigational pandemic influenza vaccine in healthy adults aged 18 years and older. The study ...
The Boston Globe29d
Moderna shares plunge after company cuts vaccine sales outlook
Moderna had previously said it expected results from a late-stage study of its vaccine for cytomegalovirus, or CMV, a common cause of birth defects, as early as the end of 2024. But Moderna said ...
Miami Herald1mon
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Latent and other vaccines: Cytomegalovirus (CMV) vaccine: The pivotal Phase 3 study of Moderna's CMV vaccine candidate (mRNA-1647) is fully enrolled and accruing cases, evaluating its efficacy ...
Why Is Moderna Stock Trading Higher On Tuesday?
Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department of Health ...